AMSBIO: Cryopreservation Excipient for Cell Therapies

Hits:692   Date: 9/15/2021

AMSBIO has launched STEM-CELLBANKER® EX - a next generation cryopreservation product that eliminates the need for the traditional washing steps required in cell therapy product development.

Rapid developments in cell, tissue, and gene therapies over the last decade have redefined what a cell therapy can be. The use of living cells as the active medicinal ingredient present great opportunities to deliver treatment that can trigger the body’s own capacity to regenerate damaged or diseased tissue. However, the development of a cell therapy using a process that includes the washing out of the cryopreservation solution is not only inconvenient but can result in loss of cells and lower cell viability. Due to its unique formulation, STEM-CELLBANKER® EX eliminates the need for this step.
 

Illustration of embryonic stem cells

Assisting easier implementation in a clinical environment - STEM-CELLBANKER® EX is a chemically defined cryopreservation media solution that only includes components registered as inactive ingredients that have already been approved for intravenous administration. Manufactured under strict US, EU and PIC/S GMP guidelines - STEM-CELLBANKER® EX is a serum free and animal component free, sterile DMSO-containing solution optimized for cryopreserving human cells, tissues and organoids.
 

Cryopreserved sample held with tweezers

Proven to maintain cell pluripotency, normal karyotype, and proliferation ability post-thaw - STEM-CELLBANKER® EX delivers consistently higher cell viability and cell recovery than other cryopreservation media.

For further information please visit https://www.amsbio.com/stem-cell-cryopreservation-ex/  or contact AMSBIO on+44-1235-828200 / +1-617-945-5033 / info@amsbio.com.

Founded in 1987, AMS Biotechnology (AMSBIO) is recognized today as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for research and development in the medical, nutrition, cosmetics and energy industries. AMSBIO has in-depth expertise in extracellular matrices to provide elegant solutions for studying cell motility, migration, invasion and proliferation. This expertise in cell culture and the ECM allows AMSBIO to partner with clients in tailoring cell systems to enhance organoid and spheroid screening outcomes using a variety of 3D culture systems, including organ-on-a-chip microfluidics. For drug discovery research, AMSBIO offers assays, recombinant proteins and cell lines. Drawing upon a huge and comprehensive biorepository, AMSBIO is widely recognised as a leading provider of high-quality tissue specimens (including custom procurement) from both human and animal tissues. The company provides unique clinical grade products for stem cell and cell therapy applications these include high quality solutions for viral delivery (lentivirus, adenovirus and adeno-associated virus) in addition to GMP cryopreservation technology.

Worldwide HQ

AMS Biotechnology (AMSBIO)
184 Milton Park
Abingdon
Oxon OX14 4SE
UK
Tel: +44-1235-828200
Fax: +44-1235-820482
Email: info@amsbio.com
Web www.amsbio.com
 
North American HQ
 
AMSBIO LLC
1035 Cambridge Street
Cambridge
MA 02141
USA
Tel: +1.617.945.5033
Tel: +1.800.987.0985 (toll free)
Email: info@amsbio.com
Web www.amsbio.com